C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies

Article

Abstract: Protein phosphatase 2A (PP2A) is an important Ser/Thr phosphatase that participates in the regulatio

Palabras claves:

Alzheimer's disease, neuroprotection, Okadaic acid, PP2A-activating drug (PAD), Protein phosphatase 2A (PP2A), Tauopathies

Autores:

Arribas R.L., de los Ríos C., García-Frutos E.M., Isaac Bravo, Janssens V., Martínez M., Montiel C., Ramos E., Romero A., Viejo L.

Fuentes:

scopus